Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 13, Number 9—September 2007


TaqMan Assay for Swedish Chlamydia trachomatis Variant

Arnold Catsburg*1, Laura van Dommelen†1, Vitaly Smelov‡§, Henry J.C. de Vries¶#, Alevtina Savitcheva‡, Marius Domeika**, Björn Herrmann††, Sander Ouburg*, Christian J.P.A. Hoebe‡‡, Anders Nilsson††, Paul H.M. Savelkoul*, and Servaas A. Morré*†§§Comments to Author 
Author affiliations: *VU University Medical Center, Amsterdam, the Netherlands; †Academic Hospital Maastricht, Maastricht, the Netherlands; ‡D.O. Ott Research Institute of Obstetrics and Gynaecology, St. Petersburg, Russia; §St. Petersburg State University, St. Petersburg, Russia; ¶Health Service Amsterdam, Amsterdam, the Netherlands; #University of Amsterdam, Amsterdam, the Netherlands; **Uppsala University, Uppsala, Sweden; ††Uppsala University Hospital, Uppsala, Sweden; ‡‡South Limburg Public Health Service, Heerlen, the Netherlands; §§City of Hope and Beckman Research Institute, Duarte, California, USA;

Main Article


Published studies and the current study on screening for the swCT variant*

Location Ct+, 
no. detected swCT variant, 
no. detected Reference
Amsterdam, the Netherlands 75 ND (3)
Dublin, Ireland 750 ND (4)
Oslo, Norway† 47 2 (5)
St. Petersburg, Russia 152 ND This study
Heerlen, the Netherlands 57 ND This study
Amsterdam, the Netherlands 30 ND This study

*swCT, Swedish Chlamydia trachomatis variant identified in Halland County, Sweden; Ct+, C. trachomatis DNA; ND, not detected.
†2 female patients: 1 originally from Sweden, 1 from Norway.

Main Article

1These authors contributed equally to the study.

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO